Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Perrigo Company plc
Nieuws
Perrigo Company plc
PRGO
NYS
: PRGO
| ISIN: IE00BGH1M568
30/04/2025
25,72 USD
(+0,39%)
(+0,39%)
30/04/2025
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Dividend
Technische analyse
TA
Toon enkel gratis nieuws
30 april 2025 ·
Perrigo Announces Quarterly Dividend
· Persbericht
23 april 2025 ·
Perrigo to Release First Quarter 2025 Financial Results on May 7, 2025
· Persbericht
12 september 2024 ·
Perrigo Announces The Pricing Of A Senior Notes Offering By Its Finance Subsidiary, Perrigo Finance Unlimited Company
· Persbericht
4 september 2024 ·
Perrigo Appoints Industry Veteran, Charles Atkinson, as Executive Vice President, General Counsel and Secretary
· Persbericht
27 augustus 2024 ·
Perrigo to Attend the Piper Sandler Growth Frontiers Conference
· Persbericht
19 augustus 2024 ·
Perrigo Appoints David Ball to the Newly Created Position of Executive Vice President and Chief Brand and Digital Officer
· Persbericht
2 augustus 2024 ·
Perrigo Reports Second Quarter 2024 Financial Results From Continuing Operations
· Persbericht
1 augustus 2024 ·
Perrigo Announces Quarterly Dividend
· Persbericht
31 juli 2024 ·
Perrigo to Attend the Canaccord Genuity 44th Annual Growth Conference
· Persbericht
19 juli 2024 ·
Perrigo to Release Second Quarter 2024 Financial Results on August 2, 2024
· Persbericht
10 juli 2024 ·
Perrigo Completes Divestment of HRA Pharma Rare Diseases Business
· Persbericht
28 mei 2024 ·
Perrigo to Attend Oppenheimer 24th Annual Consumer Growth & E-Commerce Conference
· Persbericht
7 mei 2024 ·
Perrigo Reports First Quarter 2024 Financial Results From Continuing Operations
· Persbericht
7 mei 2024 ·
Perrigo Announces Executive Transition for its Consumer Self-Care International (CSCI) Business
· Persbericht
1 mei 2024 ·
Perrigo Announces Quarterly Dividend
· Persbericht
25 april 2024 ·
Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million
· Persbericht
23 april 2024 ·
Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024
· Persbericht
9 april 2024 ·
Opill and WNBA Team Up for Groundbreaking Partnership
· Persbericht
4 maart 2024 ·
Perrigo Commences Shipments of Opill® to Retailers Nationwide, Empowering Millions to Enter a New Era of Reproductive Health Access in the United States
· Persbericht
29 februari 2024 ·
Perrigo to Attend UBS Global Consumer and Retail Conference
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe